A tumor-targeting cRGD-EGFR siRNA conjugate and its anti-tumor effect on glioblastoma in vitro and in vivo

The epidermal growth factor receptor (EGFR) is an important anti-tumor target. The development of novel molecular-targeted anti-tumor drugs that can target the interior of tumor cells and specifically silence EGFR expression is valuable and promising. In this work, a promising anti-tumor conjugate c...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Drug Deliv
Päätekijät: He, Shuai, Cen, Bohong, Liao, Lumin, Wang, Zhen, Qin, Yixin, Wu, Zhuomin, Liao, Wenjie, Zhang, Zhongyi, Ji, Aimin
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Taylor & Francis 2017
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC8241002/
https://ncbi.nlm.nih.gov/pubmed/28181832
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/10717544.2016.1267821
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia